FIGURE

Fig. 6

ID

ZDB-FIG-250813-34

Publication

Zimmerman et al., 2025 - Investigating Psychopharmaceutical Effects on Early Vertebrate Development Using a Zebrafish Model System

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6

(A–F) Immunohistochemical evaluation of zebrafish brain following exposure to AY9944 and psychopharmaceuticals. Immunofluorescence of HuC/D (green, pan-neuronal stain) and DAPI (blue, nuclear). (A) Measurements of immunolabeled zebrafish brains were taken from the dorsal view. Measurement i: outlines the optic tectum. Measurement ii: measures the distance between tectums and spans from the most medial side of the left optic tectum to the most medial side of the right optic tectum. Measurement iii: outlines the cerebellum. Measurement iv: outlines the midbrain. Measurement v: outlines the mesencephalon between the optic tectums. Measurement vi: measures forebrain length from the most lateral side on the left side of the forebrain to the most lateral side on the right side of the forebrain. Measurement vii: outlines the forebrain. (B) VEH-treated zebrafish brain. (C) AY9944-treated zebrafish brain. (D) CAR-treated zebrafish brain. (E) ARI-treated zebrafish brain. (F) TRZ-treated zebrafish brain. Images were taken at a magnification of 10X and enhanced for viewing. Analyses were performed on raw images. Scale bar: 100 µm.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Dev Biol